Production and Supply of α-Particle-Emitting Radionuclides for Targeted α-Therapy. 2021

Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
Life Sciences Division, TRIUMF, Vancouver, British Columbia, Canada; vradchenko@triumf.ca.

Encouraging results from targeted α-therapy have received significant attention from academia and industry. However, the limited availability of suitable radionuclides has hampered widespread translation and application. In the present review, we discuss the most promising candidates for clinical application and the state of the art of their production and supply. In this review, along with 2 forthcoming reviews on chelation and clinical application of α-emitting radionuclides, The Journal of Nuclear Medicine will provide a comprehensive assessment of the field.

UI MeSH Term Description Entries
D000512 Alpha Particles Positively charged particles composed of two protons and two NEUTRONS, i.e. equivalent to HELIUM nuclei, which are emitted during disintegration of heavy ISOTOPES. Alpha rays have very strong ionizing power, but weak penetrability. Alpha Rays,Alpha Radiation,Radiation, Alpha,Alpha Particle,Alpha Ray,Particle, Alpha,Particles, Alpha,Ray, Alpha,Rays, Alpha
D016499 Radioimmunotherapy Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY). Immunoradiotherapy,Immunoradiotherapies,Radioimmunotherapies

Related Publications

Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
January 2014, Immunotherapy,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
July 2011, Current radiopharmaceuticals,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
June 2019, Journal of medical imaging and radiation sciences,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
January 2022, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
December 2004, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
June 2014, Physics in medicine and biology,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
March 2022, Journal of nuclear medicine technology,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
January 2018, Current radiopharmaceuticals,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
January 2004, Nuclear medicine review. Central & Eastern Europe,
Valery Radchenko, and Alfred Morgenstern, and Amir R Jalilian, and Caterina F Ramogida, and Cathy Cutler, and Charlotte Duchemin, and Cornelia Hoehr, and Ferrid Haddad, and Frank Bruchertseifer, and Haavar Gausemel, and Hua Yang, and Joao Alberto Osso, and Kohshin Washiyama, and Kenneth Czerwinski, and Kirsten Leufgen, and Marek Pruszyński, and Olga Valzdorf, and Patrick Causey, and Paul Schaffer, and Randy Perron, and Samsonov Maxim, and D Scott Wilbur, and Thierry Stora, and Yawen Li
August 2014, AJR. American journal of roentgenology,
Copied contents to your clipboard!